SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?


To: Tim Luke who wrote (16196)12/21/1998 8:29:00 AM
From: Henry Niman  Respond to of 18691
 
This morning Paine Webber and BBRS raised AMGN target price to $120 and $116 respectively and PW raise rating from ATTRACTIVE to BUY. Joe Kernan just gave an analysis of the NESP decision (said that Epogen was #1 seller for AMGN and JNJ and was most successful Biotech drug). Gordon Binder (AMGN CEO) will be on shortly. Details linked to Biotech Boom table at biocognizance.com